Health Products

JAMP Guanfacine XR 1 mg tablets: One lot recalled as some bottles may also contain higher strength tablets

· Published by Health Canada · Official notice

Details

Alert type: Public advisory
Category: Health products
Product: JAMP Guanfacine XR 1 mg tablets
Issue: Health products - Product safety
What to do: Check your or your child's pill bottle to ensure it contains only white, round JAMP Guanfacine XR 1 mg tablets. If it contains any green, oval JAMP Guanfacine XR 4 mg tablets, or if you are unsure, return it to your pharmacy. Your pharmacist will check it and provide you with a replacement if needed. Contact a health care professional immediately if you or your child are experiencing signs and symptoms of overdose (described below).
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Images

Products

Expiry dateDINProductLot number
2024-SE02523558JAMP Guanfacine XR 1 mg tabletsGFO2012

Issue

JAMP Pharma Corporation is recalling one lot of JAMP Guanfacine extended release (XR) 1 mg tablets because some bottles may contain JAMP Guanfacine XR 4 mg tablets in addition to the correct strength of 1 mg tablets. Patients taking a 4 mg tablet instead of a prescribed 1 mg tablet will unexpectedly receive a higher dose than intended, which may result in overdose and could pose serious health risks.

JAMP Guanfacine XR is a prescription drug used to treat Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents 6 to 17 years of age.

The 1 mg tablet is white and round with the letters 'GNF' stamped on one side and '1MG' stamped on the other.

The 4 mg tablet is green and oval with the letters 'GNF' stamped on one side and '4MG' stamped on the other.

Signs and symptoms of guanfacine overdose may include hypertension (high blood pressure), hypotension (low blood pressure), bradycardia (slow heartbeat) or abnormal heart rhythms, lethargy (drowsiness/feeling tired), respiratory depression (slowed breathing), or coma (loss of consciousness). It may take up to 24 hours for signs and symptoms of overdose to appear after taking too much of the product. Patients with suspected overdose should consult their health care professional immediately, as they may require monitoring in hospital.

Health Canada is monitoring the company's recall, and its implementation of any necessary corrective and preventative actions to stop this issue from reoccurring. The Department will inform the public if any new health risks are identified.

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime